|
生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
|
ヒト・動物細胞
|
SSP-25(RCB1293)
,
RBE(RCB1292)
|
87317
|
IL-33 released during liver resection facilitates intrahepatic cholangiocarcinoma growth via cytokine secretion in cancer-associated fibroblasts.
|
Br J Cancer |
2026-2-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
RBE(RCB1292)
,
SSP-25(RCB1293)
,
TFK-1(RCB2537)
|
87234
|
PufA drives cholangiocarcinoma progression via NFκB signaling activation: a novel therapeutic target.
|
Cancer Gene Ther |
2026-1-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
RBE(RCB1292)
|
86222
|
METTL3-mediated m6A methylation on lncRNA H19 inhibits intrahepatic cholangiocarcinoma progression through PPARγ downregulation.
|
Int J Biol Sci |
2025-1-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
SSP-25(RCB1293)
,
HuCCT1(RCB1960)
|
84395
|
Heteronemin suppresses EGF‑induced proliferation through the PI3K/PD‑L1 signaling pathways in cholangiocarcinoma.
|
Oncol Rep |
2025-3-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
TFK-1(RCB2537)
|
83150
|
Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866.
|
Int J Mol Sci |
2025-1-24 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
RBE(RCB1292)
,
SSP-25(RCB1293)
|
82841
|
Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression.
|
Molecules |
2024-7-18 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
|
82661
|
Revolutionizing drug delivery: low-intensity pulsed ultrasound (LIPUS)-driven deep penetration into hypoxic tumor microenvironments of cholangiocarcinoma.
|
Theranostics |
2025-1-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
TFK-1(RCB2537)
|
81791
|
SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells.
|
Front Biosci (Schol Ed) |
2024-9-29 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
|
79180
|
FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.
|
Nat Commun |
2024-5-7 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
RBE(RCB1292)
|
79009
|
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.
|
Cancer Discov |
2022-5-2 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
RBE(RCB1292)
|
72037
|
KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression.
|
Liver Int |
2022-10-1 |
Pubmed
Full text
|